Latest Articles

Publication Date
Circulating Tumor DNA in Ovarian Cancer: Emerging Roles in Early Detection, Risk Stratification, and Disease Monitoring.

Early diagnosis of ovarian cancer remains one of the most important unmet needs in gynecologic oncology because survival is strongly stage-dependent and most patients still present with disseminated disease. Conventional …

Published: April 21, 2026, midnight
Mariam Naqvi, MD, on eliminating bias in hospital toxicology testing - Contemporary OB/GYN

Mariam Naqvi, MD, on eliminating bias in hospital toxicology testing Contemporary OB/GYN

Published: April 20, 2026, 4:29 p.m.
JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments - Roswell Park Comprehensive Cancer Center

JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments Roswell Park Comprehensive Cancer Center

Published: April 20, 2026, 1 p.m.
Feinstein Institutes' ROSE study continues to advance critical endometriosis diagnostic test - SelectScience

Feinstein Institutes' ROSE study continues to advance critical endometriosis diagnostic test SelectScience

Published: April 20, 2026, 8:49 a.m.
High response rates in platinum-resistant ovarian cancer with immunotherapy agents - MSN

High response rates in platinum-resistant ovarian cancer with immunotherapy agents MSN

Published: April 20, 2026, 8:14 a.m.
Macrophage membrane-biomimetic nanovehicles delivering amygdalin halt pyroptosis propagation and alleviate endometriosis-associated neuropathic pain.

The clinical management of endometriosis encounters a significant obstacle: existing therapies inadequately address both the inhibition of ectopic lesion proliferation and the mitigation of the neuroinflammation associated with chronic pain. …

Published: April 20, 2026, midnight
Incidence and burden of endometriosis among U.S. active component service women, 2017-2024.

Endometriosis is a complex gynecological condition affecting nearly 10% of reproductive-aged women. This report updates a 2017 MSMR report of gynecological conditions, including endometriosis, from 2012 through 2016 among U.S. …

Published: April 20, 2026, midnight
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily

BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer Oncodaily

Published: April 18, 2026, 6:23 p.m.
Lena Dunham and the art monster - New Statesman

Lena Dunham and the art monster New Statesman

Published: April 18, 2026, 1:36 a.m.
Famesick review: Lena Dunham, art monster - New Statesman

Famesick review: Lena Dunham, art monster New Statesman

Published: April 18, 2026, 1:30 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!